Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

This prestigious honor highlights Ms. McKeever's transformative contributions to Photobiomodulation (PBM) therapy, her exceptional leadership, and her dedication to advancing holistic health ...

In today’s dynamic, customizable wellness landscape, brands have a unique opportunity to stay ahead of the curve.

Several large drugmakers will ask the Trump administration to pause Medicare drug-price negotiations, even as Biden-appointed ...

Low-level laser therapy is a non-invasive treatment for TMJ symptoms that uses light to stimulate cellular activity, and it's ...

In addition, certain areas of therapy, such as self-administered injectables ... In the meantime, the PBM industry is doing an excellent job of convincing employers of the benefits of carving ...

Chromatin Bioscience is pleased to announce its ongoing collaboration with EsoBiotec, which has successfully advanced its ESO-T01 in vivo CAR-T candidate into clinical trials. ESO-T01 is the first in ...

This includes physician services, rehab therapy services ... of the bill that shine a light on what they consider inequitable PBM practices as a great initial effort to rectify a substantial ...